As of Friday close, Sabra Health Care REIT Inc.’s (NASDAQ:SBRA) stock was up $0.03, moving up 0.22 percent to $13.94. The average number of shares traded per day over the past five days has been 2,864,000 shares. 3 times new highs have been achieved over the past 5 days, with a $0.56 gain in that time frame. In the last twenty days, the average volume was 2,928,885, while in the previous 50 days, it was 2,446,704.
Since last month, SBRA stock rose 13.98%. Shares of the company fell to $12.00 on 08/25/23, the lowest level in the past month. A 52-week high of $14.13 was reached on 09/22/23 after having rallying from a 52-week low of $10.08. Since the beginning of this year, SBRA’s stock price has risen by 12.15% or $1.51, and marked a new high 13 times. However, the stock has declined by -1.34% since its 52-week high.
SBRA stock investors should be aware that Sabra Health Care REIT Inc. (SBRA) stock had its last reported insider trading activity 22 days ago on Sep 01. Costa Michael Lourenco, the Executive VP, CFO & Secretary of the company, purchased of 1,947 shares for $12.63 on Sep 01. It resulted in a $24,591 investment by the insider.
Valuation Metrics
The stock’s beta is 1.25. Besides these, the trailing price-to-sales (P/S) ratio of 5.13, the price-to-book (PB) ratio of 1.10, and the price-to-cash flow ratio of 15.86 may also be considered.
The latest dividend of $0.30 per share was paid out, remained unchanged from last year’s $0.30. On Wednesday May 6 2020, a $0.15 dividend decrease was announced.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.82, and the total debt-to-equity ratio was 0.82. On the profitability front, the trailing twelve-month gross margin is 74.00% percent. In the year ended June 29, operating margins totaled 1.30%. Based on annual data, SBRA earned $140.66 million in gross profit and brought in $624.81 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 0.60%. Return on equity (ROE) for the past 12 months was -4.00%.
In Sabra Health Care REIT Inc.’s quarter-end financial report for June 29, it reported total debt of $48.27 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. SBRA’s revenue rose 3.23% to $161.32 million during the quarter, while net income inched up to $161.17 million. While analysts expected Sabra Health Care REIT Inc. to report $0.1 quarterly earnings, the actual figure was $0.09 per share. During the quarter, the company generated $102.47 million in EBITDA. The value of shareholders’ equity is $231.22 million.
Technical Picture
This quick technical analysis looks at Sabra Health Care REIT Inc.’s (SBRA) price momentum. With a historical volatility rate of 20.07%, the RSI 9-day stood at 81.01% on 22 September.
With respect to its five-day moving average, the current Sabra Health Care REIT Inc. price is up by +4.19% percent or $0.56. At present, SBRA shares trade +14.92% above its 20-day simple moving average and +22.71% percent above its 100-day simple moving average. However, the stock is currently trading approximately +11.52% above its SMA50 and +7.15% above its SMA200.
Stochastic coefficient K was 84.65% and Stochastic coefficient D was 85.54%, while ATR was 0.33. Given the Stochastic reading of 80.10% for the 14-day period, the RSI (14) reading has been calculated as 74.07%. As of today, the MACD Oscillator reading stands at 0.41, while the 14-day reading stands at 0.64.
Analyst Ratings
Jefferies upgraded its rating on Sabra Health Care REIT Inc. (NASDAQ: SBRA) to a Buy in a note to investors on September 20, 2023. The analysts firm previously had a Hold rating on the stock.Sabra Health Care REIT Inc. (SBRA) has been rated Overweight by analysts. According to 1 brokerage firm, SBRA is a sell, and 9 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Sabra Health Care REIT Inc. stock as buy, with 5 recommending it as overweight.
With a median target price of $13.50, the current consensus forecast for the stock is $12.50 – $15.00. Based on these forecasts, analysts predict Sabra Health Care REIT Inc. (SBRA) will achieve an average price target of $13.63.
